Background : Secondary metabolites of lichens have a wide range of biological activity, including geroprotective activity, but their complex effect on the human transcriptome remains poorly understood. The aim of the study was to evaluate the effects of perlatolic acid (PA) and bromoatranorine (Br) on the transcriptomic profile of primary human dermal fibroblasts (HDFs) to identify key target genes and signaling pathways. Methods and Results: HDFs were treated with PA and Br at concentrations of 1µM and 5µM, followed by analysis by high-throughput RNA sequencing (RNA-seq). Using the SenMayo panel, the GeneAge and MatrisomeDB databases, it was shown that PA leads to a significant decrease in the expression of key SASP factors: IL6, CXCL8, CCL2, IL32, and IGFBP family genes. Both compounds led to upregulation of matrix metalloproteinase genes (MMP1, MMP3, MMP12), which, in the case of PA, was accompanied by a predominant suppression of the expression of structural genes of the core matrisome. Based on the Gene Set Enrichment Analysis (GSEA), we identified pathways, such as Cell cycle/replication, genome maintenance, ECM/fibroblast matrix, and RNA/signaling/metabolism, which were significantly modulated by exposure to PA and, to a lesser extent, Br. Conclusions: The study describes for the first time the full-transcriptomic landscape of the response of fibroblasts to lichen depsides. PA acts as an active modulator of genetic networks, stimulating proliferative cascades and remodeling of the matrix. The identified targets open up prospects for the use of PA in regenerative biomedicine, while Br has a limited effect on the transcriptome.